What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Surgery
- Analgesic
The scientist’s investigation covers issues in Placebo, Anesthesia, Adverse effect, Chronic pain and Analgesic.
Her primary area of study in Placebo is in the field of Number needed to treat.
Her Anesthesia research integrates issues from Ibuprofen, Tolerability and Etoricoxib.
Her research on Adverse effect concerns the broader Internal medicine.
Her Chronic pain study combines topics in areas such as Vitamin D and neurology, Neuropathic pain, Postherpetic neuralgia and Systematic review.
The Analgesic study which covers Cancer pain that intersects with Carbamazepine.
Her most cited work include:
- Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. (559 citations)
- Pregabalin for acute and chronic pain in adults (442 citations)
- Gabapentin for chronic neuropathic pain and fibromyalgia in adults (355 citations)
What are the main themes of her work throughout her whole career to date?
Sheena Derry mainly focuses on Placebo, Anesthesia, Adverse effect, Analgesic and Number needed to treat.
Her Placebo study integrates concerns from other disciplines, such as Neuropathic pain, Internal medicine, Clinical trial and Physical therapy, Chronic pain.
Sheena Derry has included themes like Ibuprofen and Tolerability in her Anesthesia study.
Alternative medicine is closely connected to Intensive care medicine in her research, which is encompassed under the umbrella topic of Adverse effect.
The various areas that Sheena Derry examines in her Analgesic study include Diclofenac, Cancer pain, Pain ladder, Pain assessment and Oxycodone.
The concepts of her Number needed to treat study are interwoven with issues in Osteoarthritis, Ketoprofen, Headaches and Migraine.
She most often published in these fields:
- Placebo (50.00%)
- Anesthesia (49.60%)
- Adverse effect (41.94%)
What were the highlights of her more recent work (between 2015-2019)?
- Placebo (50.00%)
- Anesthesia (49.60%)
- Number needed to treat (33.47%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Placebo, Anesthesia, Number needed to treat, Analgesic and Clinical trial.
The study incorporates disciplines such as Neuropathic pain, Relative risk, Internal medicine, Adverse effect and Physical therapy in addition to Placebo.
Her Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Acetaminophen, Surgery and Acute postoperative pain.
Her work carried out in the field of Anesthesia brings together such families of science as Hydromorphone, Oxycodone and Pain ladder.
Her work carried out in the field of Analgesic brings together such families of science as Pregabalin, Codeine, Chronic pain and Cancer pain.
Her work deals with themes such as Meta-analysis and Publication bias, which intersect with Clinical trial.
Between 2015 and 2019, her most popular works were:
- Topical NSAIDS for chronic musculoskeletal pain in adults (201 citations)
- Methadone for cancer pain (153 citations)
- Gabapentin for chronic neuropathic pain in adults (139 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
